Search This Blog

Amenorrhea

Definition

Amenorrhea is defined as absence or cessation of menses

Types : Physiological - prepubertal
Pregnancy/lactation
Menopause
Pathological - Primary
Secondary


PRIMARY AMENORRHEA is defined as absence of menses by 16 years of age in the presence of secondary sexual characteristics
or by 14 years in the absence of secondary sexual characteristics
Incidence 1-2% of women
SECONDARY AMENORRHEA is defined as the absence or cessation of menses for 6 months in a women who had previously menstruated

Normal menses
  • XX chromosome
  • intact functioning hypothalamo –pituitary axis
  • functioning ovary
  • responsive endometrium
  • patent outflow tract

At puberty there are a series of changes where there is physical growth-breast development-pubic & axillary hair growth- dev of ovaries and genital organs- growth spurt and menstruation.
Average age of menarche in Indo-Pakistani girls 13.5 yrs

Causes

OUTFLOW TRACT
intact hymen
vaginal agenesis
vaginal septa
cervical agenesis
cervical os stenosis

Cryptomenorrhea
  • primary amenorrhea in a teenage girl
  • cyclic pain abdomen
  • palpable lower abdominal mass
  • possible urinary difficulty
  • Bluish bulging membrane at lower end of vagina


Uterine

Mullerian agenesis/dysgenesis:
Rokitansky Syndrome
Androgen insensitivity (XY)

Asherman Syndrome secondary to curretage /infections like TB
damaged by RT

removed surgicaly
Congenitaly absent endometrium (v rare)

Rokitansky syndrome
  • 46XX geneticaly female
  • Mullerian agenesis(absent uterus or small rudimentary bulb with blind vagina)
  • phenotypically female
  • normal ovaries
  • Presents with primary amenorrhea
  • associated with other cong anomalies :urinary 47%, skeletal 12%,heart disease

Testicular feminization syndrome
  • Genotype male 46XY
  • Absence of cytosol androgen receptors
  • phenotypicaly female : tall with long hands and feet
  • breasts developed : peripheral conversion of testerone
  • pubic and axillary hair not well developed
  • blind vagina
  • testes are in abdomen or inguinal region

Ovarian

Agenesis /dysgenesis
Turners Syndrome (XO),mosaics
Pure gonadal dysgenesis
partial deletion of X chromosome(46xx)

exposure to RT /chemo (destroys the follicles)
surgical removal
premature ovarian failure ? Autoimmune cause
Resistant Ovary Syndrome
Polycystic ovarian disease
galactosemia : galactose has toxic effect on ovarian follicles

Turners Syndrome
  • gonadal dysgenesis 45XO
  • primary amenorrhea
  • short stature
  • absence of Sec. sexual characteristics
  • streak ovaries
  • webbed neck
  • increased carrying angle
  • shield chest
  • associated with heart and renal defects
  • Growth hormone before epiphysis close; estrogen replacement therapy later



Pituitary

Tumours : non functioning adenomas
hormone producing eg prolactinomas , hyperthyroidism etc
Empty sella syndrome :hypo pituitary function
Destruction of pituitary by
necrosis : Sheehans syndrome
infarction
infiltrative lesion eg lymphocytic hypophysitis ,
granulomatous lesions
RT or surgery

Hyperprolactinaemia
  • Due to drugs: haloperidol ,metochlorpramide ,phenothiazine, reserpine, methyldopa : decrease dopamine which inhibits prolactin
  • adenomas (micro and macro)
  • Hypothyroidism : Increased TRH stimulates PL release
  • present with galactorrhea, anovulation, oligo and amenorrhea (20%), subfertility
  • CT/MRI

Hypothalamus (decrease secretion or synthesis of GnRH)
  • physiological delay (most common)
  • Kallmanns Syndrome : insufficient secretion of GnRH
  • Tumours : craniopharyngioma ,tubercular granuloma, dermoid etc
  • anorexia nervosa, extreme exercise ,stress
  • drugs : phenothiazine,reserpine,ganglion blocking agents affect hypothalamus

Congenital adrenal hyperplasia
  • congenital defect in enzymes needed for formation of cortisol – increased ACTH production
  • increased androgen : causing ambigous genitalia, amenorrhea, virilism
  • normal looking uterus and ovaries
  • can be XY or XX
  • serum levels of 17 OH progesterone levels are raised
  • supplement small doses of corticosteroid to suppress the ACTH
  • function of ovaries and uterus possible with eraly treatment

Diagnosis
Clinical history
Examination
Investigation


History

Age
detailed menstrual history
secondary sexual development
associated symptoms : pain
mass
pregnancy related symptoms
headache, visual disturbances
discharge from breast
menopausal symptoms
diet ,recent change in weight or voice

Parity , recent birth related haemorrhage,need for curretage for abortion or PPH
contraceptive history : post pill or depo related amenorrhea
Past medical : TB,DM(vasculitis can damage pituitary), psychological disorders with medications, Cushings syndrome, adrenal disorders,thyroid disorders ,cancers needing RT/Chemo
Past Surgical history : oopherectomy or hysterectomy, D/C , cranial surgeries etc

Personal : use of any drugs, exercise
Family history : mother and sisters age of onset of menses

Examination

General habitus : cachexic ,obese, truncal obesity, enlarged facial features and hands and feet
height and weight

Limbs : cubitus valgus
Secondary sexual characteristics ; breast , pubic and axillary hair
Neck : short webbed neck, LN, thyroid
Chest : shield chest ,widely spaced nipples, milky discharge from breast

PA : mass perabdominal or in inguinal region

PV: ambiguos genitalia, labial fusion, absent or short vagina, imperforate hymen(bluish bulge at introitus), absence of uterus, palpable ovarian mass

PR : confirm mass anteriorly or absence of uterus/vagina . Finger can easily feel a metal catheter in the urethra in case of vaginal agenesis ,but not in case of crptomenorrhoea

Investigation

From the examination outflow tract obstruction is evident .eg agenesis of vagina,uterus
crytomenorrhoea,haematometra
In cases of vaginal agenesis the presence of uterus and ovaries need to be confirmed .
USG - uterus ovaries presence,size
collection within uterus
collection within vagina
pregnancy
PCOD
endometrial thickness

Uterus
absent present
Mullerian agenesis vaginal agenesis
True hermaphrodite septa
cryptomenorrhea
Androgen insenstivity Cervical stenosis
Ashermans Syndrome

Karyotyping ,especially in case of ambigous genitalia

No anatomical defect, pregnancy ruled out , uterus present

Serum Prolactin functioning uterus
Serum TSH estrogenized or not

Progestin Challenge Test
5mg MPA daily for 5 days –withdrawl bleeding within a week
POSITIVE NEGATIVE
bleeding present No bleeding
Endogenous estrogen present No estrogen production

Estrogenized endometrium estrogen/progesterone
Patent outflow supplementation
No bleeding withdrawl
PCOD endometrial damage
positive withdrawl
Serum FSH,LH, PL,TSH
* Low FSH (<40iu/L) constituitional delay
Low LH (<5iu/L) Hypothalamic causes
(hypoGn,hypo gonadism)
* High FSH (>40iu/L) ovarian failure
(hyper Gn ,hypogonadism)
* PL increased hyperprolactinaemia
* TSH increased hypothyroidism

Management

Based on the cause
outflow tract obstruction :
cryptomenorrhea : hymenectomy using cruciate incision
septa : excision
haematometra : cervical dilation/drainage
vaginal agenesis : vaginoplasty





Mullerian agenesis : counseling, adoption

Ashermans syndrome : hysteroscopic breakdown of adhesions ,IUCD kept for 10-12 months to deter reformation

Ovarian dysgensis or failure : HRT supplementation in case of Y chromosome testes is to be removed,as there is 50% chance of malignancy arising from such a gonad
PCOD : medicaly ovulation induction, progesterone supplementation
Testicular feminization : treat patient as female, remove gonads , estrogen suplementation

Hyperprolactinaemia :
lateral skull Xray : enlargement of pit fossa, destruction of clinoid process - CT scan
medicaly : bromocryptine /cabergoline (D agonist)
Surgicaly : macroadenomas with pressure symptoms

Importance of amenorrhea
  • psychosocial development delays, physical sexual abnormalities
  • ? Problems with identity : ?male? Female
  • coital difficulty
  • Pain /Mass
  • infertility
  • risk of malignancy in XY cases: 50%
  • hypoestrogenic status : risk of osteoporosis
  • Hyperestrogenic status : risk of endometrial cancer

DYSFUNCTIONAL UTERINE BLEEDING (DUB)




Abnormal bleeding from the uterus in the absence of any organic disease in the genital tract

10 % of women attending gynecologycal OPD

Classification

According to functional abnormality

Anovulatory DUB

Ovulatory DUB


Clinical time of presentation

5-7 yrs following menarche (puberty menorrhagia)

20-25 yrs of mature reproductive life (corpus luteum dysfunction)

5-7 yrs preceding menopause (perimenopausal DUB)

Pathophysiology of DUB :

Anovulatory DUB

Dysfunction of hypothalamo-pituitary ovarian axis due to impaired response of hypothalamus or immaturity of estrogen feedback mechanism

Under the estrogenic influence
Hyperplasia of endometrium
Fragile supporting stromal tissue of endometrium
Endometrium outgrow the estrogen support
Estrogen threshold bleeding – not enough estrogen to support endometrial growth

Causes local disturbance in the endometrium due to imbalance in the production of vasodilator and vasoconstrictor prostaglandin (↑ PG E2- ↑ vasodilatation)

Ovulatory DUB

Corpus luteum hypo function (insufficiency/ irregular ripening)- disordered growth of endometrium
Corpus luteum hyper function (persistent corpus luteum)- continued secretion of estrogen and progesterone - absence of sharp fall- irregular shedding
↑ PGF2α -↑vasoconstriction- endothelial damage
↑ plasminogen/ fibrinolytic activity -↑ bleeding

Histopathology
Normal endometrium
Proliferative endometrium/Secretory endometrium
Disordered growth, irregular ripening, irregular shedding
Atrophic endometrium

After menarche
Immaturity of hypothalamic –pituitary-ovarian axis – anovulatory DUB

In the mature reproductive age group
Hypo or hyperfunction of corpus luteum
Local disturbance in the endometrium -ovulatory DUB

In the perimenopausal group
Increased resistance of ovarian follicles
Decreased number of follicles - anovulatory DUB

Diagnosis--History

Abnormal bleeding P/V
Excessive, prolonged duration, irregular bleeding, with clots
Irregular cycle/ preceded by a variable period of amenorrhoea
Symptom of anemia
Change in daily routine activity

Clinical examination

Normal pelvic finding
Signs of anemia if bleeding is severe

Rule out secondary causes (normal pelvic findings)
IUCD, Norplant, Depo provera
Thyroid problem
Coagulation disorder

Differential diagnosis of abnormal bleeding PV

Pregnancy related bleeding
Fibroid uterus
Adenomyosis, endometriosis
PID
Endometrial / endocervical polyps, hyperplasia,
IUCD/Norplant/Depo
Malignancy of cervix / uterus
Hormone producing ovarian tumor
Trauma

Investigations

To assess severity of condition
Hb, PCV, Blood grp Rh typing

To exclude organic pathology and confirm diagnosis
USG
Endometrial biopsy
Hysteroscopy
Platelet, BT, CT
Thyroid function test

Treatment

General measures
Oral iron capsule / menstrual calendar
Blood transfusion

Medical treatment

Non hormonal – prescribed during menstruation
Tranexamic acid- Anti fibrinolytic agent
Ethamsylate- increases capillary wall strength, anti fibrinolytic activity
Anti prostaglandins-mefenamic acid

Hormonal

Progesterone for anovulatory bleeding

Reverses effect of estrogen mediated endometrial proliferation
Induce endometrial maturation
For acute control of bleeding
Cyclically for 21 days
Progesterone containing IUCD

Estrogen and Progesterone ( COCP), for needing contraceptive as well

Danazol ( testosterone derivative)-competitive inhibitor of sex steroid

GnRH analogues- suppresses gonadotropin release from pituitary


Surgical management

Therapeutic D and C

Conservative surgery or minimal invasive
surgery under hysteroscopy
Endometrial resection and endometrial ablation

Non conservative surgery
Hysterectomy

ECG Interpretations

Aortic valve replacement

Asymptomatic patient

Cardiac surgery

Cerebral vascular accident

Coronary heart disease and Hypertension
Chest Discomfort

Congestive heart failure
Elective colon surgery
Elective hip Surgery
Forearm rash

Mitral valve replacement

Pacemaker
Palpitations
Paroxysmal Atrial Fibrillation

Procainamide

Pulmonary edema

Sepsis

Severe Dyspnea

ECG Interpretations

Rheumatic Fever

Atrial fibrillation with Nausea and Dehydration

Recurrent Chest pain

Chronic Dyspnea on Exertion

Diaphoresis and Dyspnea

Atrial Fibrillation and Atrial flutter

Lightheadedness

Diastolic murmur

Mild indigestion

Myocardial infarction

ECG Interpretations

ECG of Atypical Chest pain


ECG of CCU-coronary care unit- include Medication

ECG of Preoperative evaluation

ECG of CCU -coronary care unit

ECG of Chest pain

ECG of Congestive heart failure (a)

ECG of Congestive heart failure (b)

ECG of Chest discomfort